1Allina J, Hu B, Sullivan DM, et al. T cell targeting and phagocytosis of apoptotic biliary epithelial cells in primary hiliary cirrhosis. J Autoimmun, 2006, 27: 232-241.
2He XS, Ansari AA, Ridgway WM, et al. New insights to the immunopathology and autoimmune responses in primary biliary cirrhosis. Cell Immunol, 2006, 239: 1-13.
3Van de Water J, Gershwin ME, Leung P, et al. The autoepitope of the 74 kD mitochondrial autoantigen of primary biliary cirrhosis corresponds to the functional site of dihydrolipoamide acetyltransferase. J Exp Med, 1988, 167: 1791 -1799.
4Shimoda S, Van de Water J, Ansari A, et al. Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis. J Clin Invest, 1998, 102: 1831-1840.
5Leon MP, Bassendine MF, Wilson JL, et al. Immunogenicity biliary epithelium: investigation of antigen presentation to CD4 + T cells. Hepatology, 1996, 24:561- 567.
6Aoki CA, Roifman CM, Lian ZX, et al. IL -2 receptor alpha deficiency and features of primary biliary cirrhosis. J Autoimmun, 2006, 27: 50-53.
7Zeniya M. Lessons from animal models of primary biliary cirrhosis. J Gastroenrol Hepatol, 2000, 15:342- 343.
8Okada C, Akbar SM, Horiike N, et al. Early development of primary biliary cirrhosis in female C57BL/6 mice because of poly I:C administration. Liver Int, 2005, 25:595- 603.
9Lyons PA, Hancock WW, Denny P, et al. The NOD Idd9 genetic interval influences the pathogenicity of insulitis and contains molecular variants of Cd30, Tnfr2, and Cd137. Immunity, 2000, 13:107-115.
10Irie J, Wu Y, Wicker LS, et al. NOD. c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogeneticaliy models human primary biliary cirrhosis. J Exp Med, 2006, 203:1209-1219.
4Domenicali M, Caracen P, Giannone F, et al. A novel model ofCC14 induced cirrhosis with ascites in the mouse [ J I. Joum of Hepatology,2009, (51) :991 -999.
5TALWALKAR JA,SOUTO E,JORGENSEN RA,et al.Natural history of pruritus in primary biliary cirrhosis[J].Clin Gastroenterol Hepatol,2003,1(4):297-302.
6KUIPER EM,HANSEN BE,DE VRIES RA,et al.Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid[J].Gastroenterology,2009,136(4):1281-1287.
7Working Subgroup(English version)for Clinical Practice Guidelines for Primary Biliary Cirrhosis.Guidelines for the management of primary biliary cirrhosis:the intractable hepatobiliary disease study group supported by the Ministry of Health,Labour and Welfare of Japan[J].Hepatol Res,2014,44(Suppl S1):71-90.
8KOHJIMA M,ENJOJI M,YADA R,et al.Pathophysiological analysis of primary biliary cirrhosis focusing on choline/phospholipid metabolism[J].Liver Int,2015,35(3):1095-1102.
9INVERNIZZI P,SELMI C,GERSHWIN ME.Update on primary biliary cirrhosis[J].Dig Liver Dis,2010,42(6):401-408.
10BERNUZZI F,FENOGLI D,BATTAGLIA F,et al.Phenotypical and functional alterations of CD8 regulatory T cells in primary biliary cirrhosis[J].Autoimmune,2010,35(3):176-180.
